These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16627248)

  • 21. Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia.
    Zhou MH; Gao L; Jing Y; Xu YY; Ding Y; Wang N; Wang W; Li MY; Han XP; Sun JZ; Wang LL; Yu L
    Ann Hematol; 2012 Aug; 91(8):1235-43. PubMed ID: 22373549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols.
    Meleshko AN; Savva NN; Fedasenka UU; Romancova AS; Krasko OV; Eckert C; von Stackelberg A; Aleinikova OV
    Leuk Res; 2011 Oct; 35(10):1312-20. PubMed ID: 21596436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance.
    Rubnitz JE; Downing JR; Pui CH; Shurtleff SA; Raimondi SC; Evans WE; Head DR; Crist WM; Rivera GK; Hancock ML; Boyett JM; Buijs A; Grosveld G; Behm FG
    J Clin Oncol; 1997 Mar; 15(3):1150-7. PubMed ID: 9060558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006.
    Thörn I; Forestier E; Thuresson B; Wasslavik C; Malec M; Li A; Lindström-Eriksson E; Botling J; Barbany G; Jacobsson S; Olofsson T; Porwit A; Sundström C; Rosenquist R
    Eur J Haematol; 2010 Feb; 84(2):117-27. PubMed ID: 19895569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in childhood acute lymphoblastic leukemia using a low-cost PCR strategy.
    Assumpção JG; Ganazza MA; de Araújo M; Silva AS; Scrideli CA; Brandalise SR; Yunes JA
    Pediatr Blood Cancer; 2010 Dec; 55(7):1278-86. PubMed ID: 20730889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
    Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome and Prognostic Factors for
    Lee JW; Kim SK; Jang PS; Chung NG; Jeong DC; Kim M; Cho B; Kim HK
    Cancer Res Treat; 2017 Apr; 49(2):446-453. PubMed ID: 27506214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
    Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
    Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.
    Alm SJ; Engvall C; Asp J; Palmqvist L; Abrahamsson J; Fogelstrand L
    Int J Lab Hematol; 2017 Apr; 39(2):121-128. PubMed ID: 28004528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing.
    Jin Y; Wang X; Hu S; Tang J; Li B; Chai Y
    Cancer Med; 2016 Feb; 5(2):337-51. PubMed ID: 26711002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of 11q23 is a highly specific nonrandom secondary genetic abnormality of ETV6/RUNX1-rearranged childhood acute lymphoblastic leukemia.
    Attarbaschi A; Mann G; Strehl S; König M; Steiner M; Jeitler V; Lion T; Dworzak MN; Gadner H; Haas OA
    Leukemia; 2007 Mar; 21(3):584-6. PubMed ID: 17215856
    [No Abstract]   [Full Text] [Related]  

  • 34. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
    Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
    J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.
    Duployez N; Nibourel O; Marceau-Renaut A; Willekens C; Helevaut N; Caillault A; Villenet C; Celli-Lebras K; Boissel N; Jourdan E; Dombret H; Figeac M; Preudhomme C; Renneville A
    Am J Hematol; 2014 Jun; 89(6):610-5. PubMed ID: 24616160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of der(12)t(12;21)(p13;q22) and as well as additional rearrangements of chromosome 12 homolog in ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Stanchescu R; Betts DR; Rechavi G; Amariglio N; Trakhtenbrot L
    Cancer Genet Cytogenet; 2009 Apr; 190(1):26-32. PubMed ID: 19264230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection.
    Li A; Zhou J; Zuckerman D; Rue M; Dalton V; Lyons C; Silverman LB; Sallan SE; Gribben JG
    Blood; 2003 Dec; 102(13):4520-6. PubMed ID: 12946997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical applications of the study of immunoglobulin and T-cell receptor gene rearrangements in acute leukemia and non-Hodgkin's lymphoma in children].
    Schütt S; Seeger K; Henze G
    Klin Padiatr; 1990; 202(4):218-23. PubMed ID: 2395311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.